By: Kevin Dinneen
The data also shows improvements in all areas of health and well-being for older people being prescribed CBPMs
Kevin Dinneen is a Co-Founder of leafie, a publication focused on cannabis-related news and information. With a passion for exploring the intersection of science, culture, and policy, Kevin's articles cover a range of topics including the impact of cannabis legalization, health benefits of cannabis, and the evolving landscape of drug policy.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Kevin Dinneen's coverage predominantly focuses on cannabis, drug policy, and health-related scientific research. His articles often involve citing data and referencing government announcements or legal policy regulations.
When reaching out to Kevin, consider providing insights from credible experts in the fields of cannabis research, drug policy analysis, or public health. Additionally, offering access to relevant datasets or discussing the implications of recent government announcements related to these topics could be particularly appealing.
Since there is no specific geographic focus mentioned for Kevin's coverage area, pitches with an international perspective on cannabis legalization policies and scientific findings may be well received by him.
This information evolves through artificial intelligence and human feedback. Improve this profile .